Immunocore Holdings plc - American Depositary Shares —— 资产负债表 (NASDAQ:IMCR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 ———597 M1.01 B1.07 B 负债总额 ———228.16 M648.79 M686.24 M 权益总额 ———368.84 M360.72 M381.03 M 负债及股东权益总额 ———597 M1.01 B1.07 B 总债务 ———48.01 M391.01 M393.13 M 净债务 ———-394.62 M-429.36 M-471.03 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

新闻

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies因营收担忧下调Immunocore股票评级

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore在Leerink会议上展示战略增长与创新

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

Immunocore HoldingsQ4每股收益及营收逊于预期

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y